| 1 | Relationship between premature ventricular complexes and stroke mortality in the general population. (Ahmad MI, Soliman MZ, Soliman EZ) J Electrocardiol 2023;77:41-45 2 Citations |
| 1 | Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC). (EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)) Lancet 2021 Nov 06;398(10312):1713-1725 222 Citations |
| 1 | Cardiotoxicity screening of long-term, breast cancer survivors-The CAROLE (Cardiac-Related Oncologic Late Effects) Study. (Puckett LL, Saba SG, Henry S, Rosen S, Rooney E, Filosa SL, Gilbo P, Pappas K, Laxer A, Eacobacci K, Kapyur AN, Robeny J, Musial S, Chaudhry A, Chaudhry R, Lesser ML, Riegel A, Ramoutarpersaud S, Rahmani N, Shah A, Papas V, Dawodu T, Charlton J, Knisely JPS, Lee L) Cancer Med 2021 Aug;10(15):5051-5061 17 Citations |
| 1 | Non-obstructive coronary angiogram findings prior to kidney transplantation do not predict post-transplant cardiac events. (Aziz F, Dhingra R, Anders M, Parajuli S, Mandelbrot D, Djamali A) Clin Nephrol 2020 Dec;94(6):273-280 4 Citations |
| 1 | Targeted Sequencing Study to Uncover Shared Genetic Susceptibility Between Peripheral Artery Disease and Coronary Heart Disease-Brief Report. (Safarova MS, Fan X, Austin EE, van Zuydam N, Hopewell J, Schaid DJ, Kullo IJ) Arterioscler Thromb Vasc Biol 2019 Jun;39(6):1227-1233 11 Citations |
| 1 | Matrix Metalloproteinase 9 as a Predictor of Coronary Atherosclerotic Plaque Instability in Stable Coronary Heart Disease Patients with Elevated Lipoprotein(a) Levels. (Ezhov M, Safarova M, Afanasieva O, Mitroshkin M, Matchin Y, Pokrovsky S) Biomolecules 2019 Mar 29;9(4) 46 Citations |
| 1 | Comparison of Outcomes and Costs Associated With Aspirin ± Clopidogrel After Coronary Artery Bypass Grafting. (Ebrahimi R, Gupta S, Carr BM, Bishawi M, Bakaeen FG, Almassi GH, Collins J, Grover FL, Quin JA, Wagner TH, Shroyer ALW, Hattler B) Am J Cardiol 2018 Mar 15;121(6):709-714 5 Citations |
| 1 | Association of a Family History of Coronary Heart Disease With Initiation of Statin Therapy in Individuals at Intermediate Risk: Post Hoc Analysis of a Randomized Clinical Trial. (Safarova MS, Bailey KR, Kullo IJ) JAMA Cardiol 2016 Jun 01;1(3):364-6 10 Citations |
| 1 | Incorporating a Genetic Risk Score Into Coronary Heart Disease Risk Estimates: Effect on Low-Density Lipoprotein Cholesterol Levels (the MI-GENES Clinical Trial). (Kullo IJ, Jouni H, Austin EE, Brown SA, Kruisselbrink TM, Isseh IN, Haddad RA, Marroush TS, Shameer K, Olson JE, Broeckel U, Green RC, Schaid DJ, Montori VM, Bailey KR) Circulation 2016 Mar 22;133(12):1181-8 209 Citations |
| 1 | Specific Lipoprotein(a) apheresis attenuates progression of carotid intima-media thickness in coronary heart disease patients with high lipoprotein(a) levels. (Ezhov MV, Safarova MS, Afanasieva OI, Pogorelova OA, Tripoten MI, Adamova IY, Konovalov GA, Balakhonova TV, Pokrovsky SN) Atheroscler Suppl 2015 May;18:163-9 30 Citations |
| 1 | New approaches to inhibiting platelets and coagulation. (Depta JP, Bhatt DL) Annu Rev Pharmacol Toxicol 2015;55:373-97 38 Citations |
| 1 | Minimally invasive coronary artery bypass grafting is associated with improved clinical outcomes. (Rabindranauth P, Burns JG, Vessey TT, Mathiason MA, Kallies KJ, Paramesh V) Innovations (Phila) 2014;9(6):421-6 41 Citations |
| 1 | Inactivating mutations in NPC1L1 and protection from coronary heart disease. (Myocardial Infarction Genetics Consortium Investigators, Stitziel NO, Won HH, Morrison AC, Peloso GM, Do R, Lange LA, Fontanillas P, Gupta N, Duga S, Goel A, Farrall M, Saleheen D, Ferrario P, König I, Asselta R, Merlini PA, Marziliano N, Notarangelo MF, Schick U, Auer P, Assimes TL, Reilly M, Wilensky R, Rader DJ, Hovingh GK, Meitinger T, Kessler T, Kastrati A, Laugwitz KL, Siscovick D, Rotter JI, Hazen SL, Tracy R, Cresci S, Spertus J, Jackson R, Schwartz SM, Natarajan P, Crosby J, Muzny D, Ballantyne C, Rich SS, O'Donnell CJ, Abecasis G, Sunaev S, Nickerson DA, Buring JE, Ridker PM, Chasman DI, Austin E, Kullo IJ, Weeke PE, Shaffer CM, Bastarache LA, Denny JC, Roden DM, Palmer C, Deloukas P, Lin DY, Tang ZZ, Erdmann J, Schunkert H, Danesh J, Marrugat J, Elosua R, Ardissino D, McPherson R, Watkins H, Reiner AP, Wilson JG, Altshuler D, Gibbs RA, Lander ES, Boerwinkle E, Gabriel S, Kathiresan S) N Engl J Med 2014 Nov 27;371(22):2072-82 382 Citations |
| 1 | Dramatic fate of a young coronary heart disease patient rescued with specific lipoprotein(a) apheresis. (Safarova MS, Ezhov MV, Afanasieva OI, Konovalov GA, Pokrovsky SN) J Clin Apher 2015 Jun;30(3):193-5 2 Citations |
| 1 | Loss-of-function mutations in APOC3, triglycerides, and coronary disease. (TG and HDL Working Group of the Exome Sequencing Project, National Heart, Lung, and Blood Institute, Crosby J, Peloso GM, Auer PL, Crosslin DR, Stitziel NO, Lange LA, Lu Y, Tang ZZ, Zhang H, Hindy G, Masca N, Stirrups K, Kanoni S, Do R, Jun G, Hu Y, Kang HM, Xue C, Goel A, Farrall M, Duga S, Merlini PA, Asselta R, Girelli D, Olivieri O, Martinelli N, Yin W, Reilly D, Speliotes E, Fox CS, Hveem K, Holmen OL, Nikpay M, Farlow DN, Assimes TL, Franceschini N, Robinson J, North KE, Martin LW, DePristo M, Gupta N, Escher SA, Jansson JH, Van Zuydam N, Palmer CN, Wareham N, Koch W, Meitinger T, Peters A, Lieb W, Erbel R, Konig IR, Kruppa J, Degenhardt F, Gottesman O, Bottinger EP, O'Donnell CJ, Psaty BM, Ballantyne CM, Abecasis G, Ordovas JM, Melander O, Watkins H, Orho-Melander M, Ardissino D, Loos RJ, McPherson R, Willer CJ, Erdmann J, Hall AS, Samani NJ, Deloukas P, Schunkert H, Wilson JG, Kooperberg C, Rich SS, Tracy RP, Lin DY, Altshuler D, Gabriel S, Nickerson DA, Jarvik GP, Cupples LA, Reiner AP, Boerwinkle E, Kathiresan S) N Engl J Med 2014 Jul 03;371(1):22-31 901 Citations |
| 1 | Association of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56,000 whites and blacks. (Peloso GM, Auer PL, Bis JC, Voorman A, Morrison AC, Stitziel NO, Brody JA, Khetarpal SA, Crosby JR, Fornage M, Isaacs A, Jakobsdottir J, Feitosa MF, Davies G, Huffman JE, Manichaikul A, Davis B, Lohman K, Joon AY, Smith AV, Grove ML, Zanoni P, Redon V, Demissie S, Lawson K, Peters U, Carlson C, Jackson RD, Ryckman KK, Mackey RH, Robinson JG, Siscovick DS, Schreiner PJ, Mychaleckyj JC, Pankow JS, Hofman A, Uitterlinden AG, Harris TB, Taylor KD, Stafford JM, Reynolds LM, Marioni RE, Dehghan A, Franco OH, Patel AP, Lu Y, Hindy G, Gottesman O, Bottinger EP, Melander O, Orho-Melander M, Loos RJ, Duga S, Merlini PA, Farrall M, Goel A, Asselta R, Girelli D, Martinelli N, Shah SH, Kraus WE, Li M, Rader DJ, Reilly MP, McPherson R, Watkins H, Ardissino D, NHLBI GO Exome Sequencing Project, Zhang Q, Wang J, Tsai MY, Taylor HA, Correa A, Griswold ME, Lange LA, Starr JM, Rudan I, Eiriksdottir G, Launer LJ, Ordovas JM, Levy D, Chen YD, Reiner AP, Hayward C, Polasek O, Deary IJ, Borecki IB, Liu Y, Gudnason V, Wilson JG, van Duijn CM, Kooperberg C, Rich SS, Psaty BM, Rotter JI, O'Donnell CJ, Rice K, Boerwinkle E, Kathiresan S, Cupples LA) Am J Hum Genet 2014 Feb 06;94(2):223-32 264 Citations |
| 1 | Explaining racial disparities in outcomes after cardiac surgery: the role of hospital quality. (Rangrass G, Ghaferi AA, Dimick JB) JAMA Surg 2014 Mar;149(3):223-7 211 Citations |
| 1 | Effect of clopidogrel use post coronary artery bypass surgery on graft patency. (Ebrahimi R, Bakaeen FG, Uberoi A, Ardehali A, Baltz JH, Hattler B, Almassi GH, Wagner TH, Collins JF, Grover FL, Shroyer AL) Ann Thorac Surg 2014 Jan;97(1):15-21 41 Citations |
| 1 | Cardiac rehabilitation patient and organizational factors: what keeps patients in programs? (Turk-Adawi KI, Oldridge NB, Tarima SS, Stason WB, Shepard DS) J Am Heart Assoc 2013 Oct 21;2(5):e000418 69 Citations |
| 1 | Cardiac rehabilitation enrollment among referred patients: patient and organizational factors. (Turk-Adawi KI, Oldridge NB, Tarima SS, Stason WB, Shepard DS) J Cardiopulm Rehabil Prev 2014;34(2):114-22 40 Citations |
| 1 | How much effect of different antihypertensive medications on cardiovascular outcomes is attributable to their effects on blood pressure? (Proschan M, Ford CE, Cutler JA, Graumlich JF, Pavlik V, Cushman WC, Davis BR, Alderman MH, Gordon D, Furberg CD, Franklin SS, Blumenthal SS, Castaldo RS, Preston RA, LHAT Collaborative Research Group) Stat Med 2013 Feb 28;32(5):884-97 6 Citations |
| 1 | Integrating coronary anastomotic connectors and robotics toward a totally endoscopic beating heart approach: review of 120 cases. (Balkhy HH, Wann LS, Krienbring D, Arnsdorf SE) Ann Thorac Surg 2011 Sep;92(3):821-7 93 Citations |
| 1 | A rare complication of infective endocarditis. (Dekam MJ, Depta JP, Lincoff AM) Cleve Clin J Med 2010 May;77(5):296-7 9 Citations |
| 1 | Lipid biology. (Lomberk G) Pancreatology 2009;9(6):722-3 |
| 1 | Measuring health-related quality of life in population-based studies of coronary heart disease: comparing six generic indexes and a disease-specific proxy score. (Garster NC, Palta M, Sweitzer NK, Kaplan RM, Fryback DG) Qual Life Res 2009 Nov;18(9):1239-47 42 Citations |
| 1 | Metabonomics: a useful tool for the future surgeon. (Goldsmith P, Fenton H, Morris-Stiff G, Ahmad N, Fisher J, Prasad KR) J Surg Res 2010 May 01;160(1):122-32 70 Citations |
| 1 | The immediate impact of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial on the management of stable angina. (Atwater BD, Oujiri J, Wolff MR) Clin Cardiol 2009 Aug;32(8):E1-3 11 Citations |
| 1 | Therapy and clinical trials. (Depta JP, Krasuski RA) Curr Opin Lipidol 2009 Jun;20(3):262-3 |
| 1 | Differential effects of lipids on the risk of heart failure and coronary heart disease: the Physicians' Health Study. (Dhingra R, Sesso HD, Kenchaiah S, Gaziano JM) Am Heart J 2008 May;155(5):869-75 30 Citations |
| 1 | Lipoprotein-associated phospholipase A2 predicts progression of cardiac allograft vasculopathy and increased risk of cardiovascular events in heart transplant patients. (Raichlin E, McConnell JP, Bae JH, Kremers WK, Lerman A, Frantz RP) Transplantation 2008 Apr 15;85(7):963-8 17 Citations |
| 1 | Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation. (Raichlin E, Bae JH, Khalpey Z, Edwards BS, Kremers WK, Clavell AL, Rodeheffer RJ, Frantz RP, Rihal C, Lerman A, Kushwaha SS) Circulation 2007 Dec 04;116(23):2726-33 159 Citations |
| 1 | Understanding of the benefits of coronary revascularization procedures among patients who are offered such procedures. (Whittle J, Conigliaro J, Good CB, Kelley ME, Skanderson M) Am Heart J 2007 Oct;154(4):662-8 47 Citations |
| 1 | Systemic inflammation and metabolic syndrome in cardiac allograft vasculopathy. (Raichlin ER, McConnell JP, Lerman A, Kremers WK, Edwards BS, Kushwaha SS, Clavell AL, Rodeheffer RJ, Frantz RP) J Heart Lung Transplant 2007 Aug;26(8):826-33 55 Citations |
| 2 | Perioperative implications of charcot-marie-tooth disease during coronary artery bypass graft surgery. (Shankar V, Markan S, Gandhi SD, Iqbal Z, Novalija J, Nicolosi AC, Pagel PS) J Cardiothorac Vasc Anesth 2007 Aug;21(4):567-9 4 Citations |
| 1 | Does concordance with guideline triage recommendations affect clinical care of patients with possible acute coronary syndrome? (Katz DA, Dawson J, Beshansky JR, Rahko PS, Aufderheide TP, Bogner M, Tighouart H, Selker HP) Med Decis Making 2007;27(4):423-37 2 Citations |
| 1 | Changes in patterns of coronary revascularization strategies for patients with acute coronary syndromes (from the CRUSADE Quality Improvement Initiative). (Gogo PB Jr, Dauerman HL, Mulgund J, Ohman EM, Patel MR, Cohen DJ, Saucedo JF, Harrington RA, Gibler WB, Smith SC Jr, Peterson ED, Roe MT, CRUSADE Investigators) Am J Cardiol 2007 May 01;99(9):1222-6 42 Citations |
| 1 | Symptom expression in coronary heart disease and revascularization recommendations for black and white patients. (Hravnak M, Whittle J, Kelley ME, Sereika S, Good CB, Ibrahim SA, Conigliaro J) Am J Public Health 2007 Sep;97(9):1701-8 13 Citations |
| 1 | Functional status outcomes among white and African-American cardiac patients in an equal access system. (Kressin NR, Glickman ME, Peterson ED, Whittle J, Orner MB, Petersen LA) Am Heart J 2007 Mar;153(3):418-25 10 Citations |
| 1 | A family consultation intervention for health-compromised smokers. (Shoham V, Rohrbaugh MJ, Trost SE, Muramoto M) J Subst Abuse Treat 2006 Dec;31(4):395-402 44 Citations |
| 1 | Temporal trends in the use of early cardiac catheterization in patients with non-ST-segment elevation acute coronary syndromes (results from CRUSADE). (Tricoci P, Peterson ED, Mulgund J, Newby LK, Saucedo JF, Kleiman NS, Bhatt DL, Berger PB, Cannon CP, Cohen DJ, Hochman JS, Ohman EM, Gibler WB, Harrington RA, Smith SC Jr, Roe MT, CRUSADE Investigators) Am J Cardiol 2006 Nov 01;98(9):1172-6 44 Citations |
| 1 | Differences in triage thresholds for patients presenting with possible acute coronary syndromes: more than meets the eye. (Milch CE, Kent DM, Ruthazer R, Pope JH, Aufderheide TP, McNutt RA, Selker HP) J Investig Med 2006 Mar;54(2):76-85 1 Citation |
| 1 | Images in cardiology. Percutaneous removal of embolised vegetation from left main coronary artery. (Smith WH, Wolff MR, Kohmoto T) Heart 2006 Jan;92(1):84 2 Citations |
| 1 | Meeting highlights of the 15th annual Scientific Sessions of the American Society of Echocardiography: June 26 to 30, 2004. (Gorcsan J 3rd, Lang RM, Picard MH, Zoghbi WA, Frommelt PC, Gillam LD) J Am Coll Cardiol 2004 Dec 07;44(11):2111-6 |
| 1 | Routine intravascular ultrasound scanning guidance of coronary stenting is not associated with improved clinical outcomes. (Orford JL, Denktas AE, Williams BA, Fasseas P, Willerson JT, Berger PB, Holmes DR Jr, PRESTO Investigators) Am Heart J 2004 Sep;148(3):501-6 24 Citations |
| 1 | Postmenopausal hormone therapy: a concise guide to therapeutic uses, formulations, risks, and alternatives. (Mitchell JL, Walsh J, Wang-Cheng R, Hardman JL) Prim Care 2003 Dec;30(4):671-96 3 Citations |
| 1 | Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation. (Orford JL, Fasseas P, Melby S, Burger K, Steinhubl SR, Holmes DR, Berger PB) Am Heart J 2004 Mar;147(3):463-7 191 Citations |
| 1 | Coronary endothelial dysfunction is not rapidly reversible with ascorbic acid. (Widlansky ME, Biegelsen ES, Hamburg NM, Duffy SJ, Keaney JF Jr, Vita JA) Free Radic Biol Med 2004 Jan 01;36(1):123-30 8 Citations |
| 1 | An automated coronary artery occlusion device for stimulating collateral development in vivo. (Rys R, LaDisa JF Jr, Tessmer JP, Gu W, Kersten JR, Warltier DC, Pagel PS) J Pharmacol Toxicol Methods 2002;48(2):111-8 4 Citations |
| 1 | Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting. (Wilson SH, Fasseas P, Orford JL, Lennon RJ, Horlocker T, Charnoff NE, Melby S, Berger PB) J Am Coll Cardiol 2003 Jul 16;42(2):234-40 422 Citations |
| 1 | Treatment of concomitant carotid and coronary artery disease. Decision-making regarding surgical options. (Brown KR) J Cardiovasc Surg (Torino) 2003 Jun;44(3):395-9 27 Citations |
| 1 | The prehospital 12-lead electrocardiogram: impact on management of the out-of-hospital acute coronary syndrome patient. (Ferguson JD, Brady WJ, Perron AD, Kielar ND, Benner JP, Currance SB, Braithwaite S, Aufderheide TP) Am J Emerg Med 2003 Mar;21(2):136-42 34 Citations |
| 1 | Black-white differences in severity of coronary artery disease among individuals with acute coronary syndromes. (Whittle J, Conigliaro J, Good CB, Hanusa BH, Macpherson DS) J Gen Intern Med 2002 Nov;17(11):867-73 6 Citations |
| 1 | Oral hypoglycemic agents in coronary artery bypass grafting. (Almassi GH, Warltier D) Ann Thorac Surg 2001 Jun;71(6):2086 |
| 1 | Lessons learned in adopting endovascular techniques for treating abdominal aortic aneurysm. (Patterson MA, Jean-Claude JM, Crain MR, Seabrook GR, Cambria RA, Rilling WS, Towne JB) Arch Surg 2001 Jun;136(6):627-34 13 Citations |
| 1 | Treatment planning dosimetric parameters for a (90)Y coil source used in intravascular brachytherapy. (Patel NS, Chiu-Tsao ST, Fan P, Ahunbay E, Ravi K, Sherman W, Quon H, Pisch J, Tsao HS, Harrison LB) Cardiovasc Radiat Med 2001;2(2):83-92 11 Citations |
| 1 | Coronary artery disease prevention: what's different for women? (Bedinghaus J, Leshan L, Diehr S) Am Fam Physician 2001 Apr 01;63(7):1393-400, 1405-6 40 Citations |
| 1 | Cardiopulmonary resuscitation and emergency cardiovascular care. Acute coronary syndromes. (Aufderheide TP, Bossaert LL, Field J, Herlitz J, Leizorovicz A, Littrell KA, Ornato JP, Peberdy MA, Ribichini F) Ann Emerg Med 2001 Apr;37(4 Suppl):S163-81 1 Citation |
| 1 | Race, baseline characteristics, and clinical outcomes after coronary intervention: The New Approaches in Coronary Interventions (NACI) registry. (Marks DS, Mensah GA, Kennard ED, Detre K, Holmes DR Jr) Am Heart J 2000 Jul;140(1):162-9 31 Citations |
| 1 | Coronary artery bypass grafting in the elderly. (Hirose H, Amano A, Yoshida S, Takahashi A, Nagano N, Kohmoto T) Chest 2000 May;117(5):1262-70 59 Citations |
| 1 | [Anesthesia for MIDCAB (minimally invasive direct coronary bypass) in a patient with Tangier disease: a case report]. (Ohnishi M, Hazama A, Kita T, Mammoto T, Akamatsu T, Kambara N, Sakai T, Kishi Y) Masui 2000 Apr;49(4):407-9 1 Citation |
| 1 | Causes of transient dilatation of the left ventricle during myocardial perfusion imaging. (Robinson VJ, Corley JH, Marks DS, Eberhardt LW, Eubig C, Burke GJ, Prisant LM) AJR Am J Roentgenol 2000 May;174(5):1349-52 30 Citations |
| 1 | Prognostic value of coronary electron-beam computed tomography for coronary heart disease events in asymptomatic populations. (O'Malley PG, Taylor AJ, Jackson JL, Doherty TM, Detrano RC) Am J Cardiol 2000 Apr 15;85(8):945-8 268 Citations |
| 1 | Update in women's health. (Charney P, Walsh J, Nattinger AB) Ann Intern Med 1999 Dec 21;131(12):952-8 1 Citation |
| 1 | Functional assessment of internal mammary artery bypass grafts: case reports and review of the literature. (Seligman RW, Robinson VJ, Marks DS) Catheter Cardiovasc Interv 1999 Feb;46(2):218-22 1 Citation |
| 1 | Update in women's health. (Charney P, Walsh JM, Nattinger AB) Ann Intern Med 1998 Oct 01;129(7):551-8 10 Citations |
| 1 | Effect of direct thrombin inhibition with Bivalirudin (Hirulog) on restenosis after coronary angioplasty. (Burchenal JE, Marks DS, Tift Mann J, Schweiger MJ, Rothman MT, Ganz P, Adelman B, Bittl JA) Am J Cardiol 1998 Aug 15;82(4):511-5 30 Citations |
| 1 | Myocardial ischemia and adverse cardiac outcomes in cardiac patients undergoing noncardiac surgery with sevoflurane and isoflurane. Sevoflurane Ischemia Study Group. (Ebert TJ, Kharasch ED, Rooke GA, Shroff A, Muzi M) Anesth Analg 1997 Nov;85(5):993-9 27 Citations |
| 1 | Do patient preferences contribute to racial differences in cardiovascular procedure use? (Whittle J, Conigliaro J, Good CB, Joswiak M) J Gen Intern Med 1997 May;12(5):267-73 132 Citations |
| 1 | Blood flow capacity via direct acute myocardial revascularization. (Kohmoto T, Uzun G, Gu A, Zhu SM, Smith CR, Burkhoff D) Basic Res Cardiol 1997 Feb;92(1):45-51 18 Citations |
| 1 | Ultrarapid train stimulation versus conventional programmed electrical stimulation for induction of ventricular arrhythmias in patients with coronary artery disease. (Fisher JD, Cua MC, Platt SB, Waspe LE, Kim SG, Ferrick KJ, Roth JA) J Interv Card Electrophysiol 1997 Feb;1(1):15-21 4 Citations |
| 1 | Angiographically documented coronary artery disease in asymptomatic middle aged men suspected of silent ischaemic heart disease. (Bashir R, Khan A, Yousaf M) J Pak Med Assoc 1996 Oct;46(10):225-8 1 Citation |
| 1 | Enterogastric bile reflux during technetium-99m-sestamibi cardiac imaging. (Kabasakal L, Collier BD, Shaker R, Hellman RS, Smart S, Ozker K, Krasnow AZ, Isitman AT) J Nucl Med 1996 Aug;37(8):1285-8 17 Citations |
| 1 | Images in cardiovascular medicine. Kawasaki's disease. (Frommelt PC, Dhala A) Circulation 1995 Dec 01;92(11):3366-7 1 Citation |
| 1 | Combined valve replacement and coronary bypass grafting in osteogenesis imperfecta. (Almassi GH, Hughes GR, Bartlett J) Ann Thorac Surg 1995 Nov;60(5):1395-7 17 Citations |
| 1 | Comparison of defibrillator therapy and other therapeutic modalities for sustained ventricular tachycardia or ventricular fibrillation associated with coronary artery disease. (Choue CW, Kim SG, Fisher JD, Roth JA, Ferrick KJ, Brodman R, Frame R, Gross J, Furman S) Am J Cardiol 1994 Jun 01;73(15):1075-9 20 Citations |
| 1 | Spontaneous coronary artery embolus associated with calcific aortic stenosis. (Salka S, Almassi GH, Leitschuh ML) Chest 1994 Apr;105(4):1289-90 15 Citations |
| 1 | Postmenopausal hormone replacement: are two hormones better than one? (Wood H, Wang-Cheng R, Nattinger AB) J Gen Intern Med 1993 Aug;8(8):451-8 1 Citation |
| 1 | Adenosine A1 receptors, KATP channels, and ischemic preconditioning in dogs. (Auchampach JA, Gross GJ) Am J Physiol 1993 May;264(5 Pt 2):H1327-36 338 Citations |
| 1 | Global myocardial ischemia and reperfusion impair endothelium-dependent relaxations to aggregating platelets in the canine coronary artery. A possible cause of vasospasm after cardiopulmonary bypass. (Pearson PJ, Lin PJ, Schaff HV) J Thorac Cardiovasc Surg 1992 Jun;103(6):1147-54 60 Citations |
| 1 | Reproducibility of electrophysiologic testing during antiarrhythmic therapy for ventricular arrhythmias secondary to coronary artery disease. (Ferrick KJ, Luce J, Miller S, Mercando AD, Kim SG, Roth JA, Fisher JD) Am J Cardiol 1992 May 15;69(16):1296-9 17 Citations |
| 1 | Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. (Gross GJ, Auchampach JA) Circ Res 1992 Feb;70(2):223-33 967 Citations |
| 1 | ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries. (Yao SK, Ober JC, McNatt J, Benedict CR, Rosolowsky M, Anderson HV, Cui K, Maffrand JP, Campbell WB, Buja LM) Circ Res 1992 Jan;70(1):39-48 107 Citations |
| 1 | Effect of aspirin on local prostaglandin production and serotonin accumulation in a canine model with coronary cyclic flow variations or thrombosis. (Yao SK, Benedict CR, Rosolowsky M, McNatt J, Falinska B, Campbell WB, Buja LM, Willerson JT) J Mol Cell Cardiol 1991 Apr;23(4):473-82 18 Citations |
| 1 | Stress proteins and cardiovascular disease. (Williams RS, Benjamin IJ) Mol Biol Med 1991 Apr;8(2):197-206 17 Citations |
| 1 | Cardioplegia-induced damage to ischemic immature myocardium is independent of oxygen availability. (Baker JE, Boerboom LE, Olinger GN) Ann Thorac Surg 1990 Dec;50(6):934-9 15 Citations |
| 2 | On the detection of paramagnetic species in the adriamycin-perfused rat heart: a reappraisal. (Kalyanaraman B, Baker JE) Biochem Biophys Res Commun 1990 May 31;169(1):30-8 2 Citations |
| 1 | Synthesis of lipoxygenase and epoxygenase products of arachidonic acid by normal and stenosed canine coronary arteries. (Rosolowsky M, Falck JR, Willerson JT, Campbell WB) Circ Res 1990 Mar;66(3):608-21 111 Citations |
| 2 | Ischemia-induced changes in myocardial paramagnetic metabolites: implications for intracellular oxy-radical generation. (Baker JE, Kalyanaraman B) FEBS Lett 1989 Feb 27;244(2):311-4 43 Citations |
| 1 | Life-style changes in a cardiac rehabilitation program: the client perspective. (Frenn MD, Borgeson DS, Lee HA, Simandl G) J Cardiovasc Nurs 1989 Feb;3(2):43-55 20 Citations |
| 1 | Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids. (Dehmer GJ, Popma JJ, van den Berg EK, Eichhorn EJ, Prewitt JB, Campbell WB, Jennings L, Willerson JT, Schmitz JM) N Engl J Med 1988 Sep 22;319(12):733-40 324 Citations |
| 1 | Blood flow velocity of internal mammary artery and saphenous vein grafts to the coronary arteries. (Bandyk DF, Galbraith TA, Haasler GB, Almassi GH) J Surg Res 1988 Apr;44(4):342-51 34 Citations |
| 2 | Myocardial ischemia and reperfusion: direct evidence for free radical generation by electron spin resonance spectroscopy. (Baker JE, Felix CC, Olinger GN, Kalyanaraman B) Proc Natl Acad Sci U S A 1988 Apr;85(8):2786-9 198 Citations |
| 1 | Beneficial effects of iloprost in the stunned canine myocardium. (Farber NE, Pieper GM, Thomas JP, Gross GJ) Circ Res 1988 Feb;62(2):204-15 77 Citations |
| 1 | Nontraumatic prehospital sudden death in young adults. (Raymond JR, van den Berg EK Jr, Knapp MJ) Arch Intern Med 1988 Feb;148(2):303-8 45 Citations |
| 1 | Cooperative mediation by serotonin S2 and thromboxane A2/prostaglandin H2 receptor activation of cyclic flow variations in dogs with severe coronary artery stenoses. (Ashton JH, Ogletree ML, Michel IM, Golino P, McNatt JM, Taylor AL, Raheja S, Schmitz J, Buja LM, Campbell WB) Circulation 1987 Oct;76(4):952-9 87 Citations |
| 1 | Inhibition of cyclic flow variations in stenosed canine coronary arteries by thromboxane A2/prostaglandin H2 receptor antagonists. (Ashton JH, Schmitz JM, Campbell WB, Ogletree ML, Raheja S, Taylor AL, Fitzgerald C, Buja LM, Willerson JT) Circ Res 1986 Nov;59(5):568-78 |
| 1 | Protection of the ischaemic myocardium by L-propionylcarnitine: effects on the recovery of cardiac output after ischaemia and reperfusion, carnitine transport, and fatty acid oxidation. (Paulson DJ, Traxler J, Schmidt M, Noonan J, Shug AL) Cardiovasc Res 1986 Jul;20(7):536-41 134 Citations |
| 1 | Serotonin as a mediator of cyclic flow variations in stenosed canine coronary arteries. (Ashton JH, Benedict CR, Fitzgerald C, Raheja S, Taylor A, Campbell WB, Buja LM, Willerson JT) Circulation 1986 Mar;73(3):572-8 |
| 1 | Cyclic blood flow variations induced by platelet-activating factor in stenosed canine coronary arteries despite inhibition of thromboxane synthetase, serotonin receptors, and alpha-adrenergic receptors. (Apprill P, Schmitz JM, Campbell WB, Tilton G, Ashton J, Raheja S, Buja LM, Willerson JT) Circulation 1985 Aug;72(2):397-405 |
| 1 | Conversion from chronic to acute coronary artery disease: speculation regarding mechanisms. (Willerson JT, Campbell WB, Winniford MD, Schmitz J, Apprill P, Firth BG, Ashton J, Smitherman T, Bush L, Buja LM) Am J Cardiol 1984 Dec 01;54(10):1349-54 121 Citations |
| 1 | Mechanism of nitroglycerin-induced coronary dilatation: lack of relation to intracoronary thromboxane concentrations. (Rehr RB, Jackson JA, Winniford MD, Campbell WB, Hillis LD) Am J Cardiol 1984 Nov 01;54(8):971-4 12 Citations |
| 1 | The effects of alpha 2-adrenergic and serotonergic receptor antagonists on cyclic blood flow alterations in stenosed canine coronary arteries. (Bush LR, Campbell WB, Kern K, Tilton GD, Apprill P, Ashton J, Schmitz J, Buja LM, Willerson JT) Circ Res 1984 Nov;55(5):642-52 |
| 1 | Acute systemic and coronary hemodynamic and serologic responses to cigarette smoking in long-term smokers with atherosclerotic coronary artery disease. (Nicod P, Rehr R, Winniford MD, Campbell WB, Firth BG, Hillis LD) J Am Coll Cardiol 1984 Nov;4(5):964-71 |
| 1 | Alterations in coronary blood flow induced by cigarette smoking: lack of relation to plasma arginine vasopressin concentrations. (Nicod P, Winniford MD, Campbell WB, Rehr RB, Firth BG, Hillis LD) Am J Cardiol 1984 Sep 01;54(6):667-8 6 Citations |
| 1 | Cigarette smoking, exercise and high density lipoprotein cholesterol. (Stamford BA, Matter S, Fell RD, Sady S, Papanek P, Cresanta M) Atherosclerosis 1984 Jul;52(1):73-83 44 Citations |
| 1 | Impedance cardiograms reliably estimate beat-by-beat changes of left ventricular stroke volume in humans. (Ebert TJ, Eckberg DL, Vetrovec GM, Cowley MJ) Cardiovasc Res 1984 Jun;18(6):354-60 79 Citations |
| 1 | Effects of the selective thromboxane synthetase inhibitor dazoxiben on variations in cyclic blood flow in stenosed canine coronary arteries. (Bush LR, Campbell WB, Buja LM, Tilton GD, Willerson JT) Circulation 1984 Jun;69(6):1161-70 |
| 1 | Improvement of myocardial function in diabetic rats after treatment with L-carnitine. (Paulson DJ, Schmidt MJ, Traxler JS, Ramacci MT, Shug AL) Metabolism 1984 Apr;33(4):358-63 69 Citations |
| 1 | The temperature dependence of the calcium paradox: enzymatic, functional and morphological correlates of cellular injury. (Baker JE, Bullock GR, Hearse DJ) J Mol Cell Cardiol 1983 Jun;15(6):393-411 35 Citations |
| 1 | Effects of provocation on transcardiac thromboxane in patients with coronary artery disease. (Hirsh PD, Firth BG, Campbell WB, Dehmer GJ, Willerson JT, Hillis LD) Am J Cardiol 1983 Mar 01;51(5):727-33 22 Citations |
| 1 | Interactions of the arterial wall, plaque, and platelets in myocardial ischemia and infarction. (Hillis LD, Hirsh PD, Campbell WB, Firth BG) Cardiovasc Clin 1983;14(1):31-44 7 Citations |
| 1 | Effect of age and coronary heart disease on the circulatory responses to graded lower body negative pressure. (Ebert TJ, Hughes CV, Tristani FE, Barney JA, Smith JJ) Cardiovasc Res 1982 Nov;16(11):663-9 47 Citations |
| 1 | Influence of blood sampling site and technique on thromboxane concentrations in patients with ischemic heart disease. (Hirsh PD, Firth BG, Campbell WB, Willerson JT, Hillis LD) Am Heart J 1982 Aug;104(2 Pt 1):234-7 20 Citations |
| 1 | Prostaglandins and ischemic heart disease. (Hirsh PD, Campbell WB, Willerson JT, Hillis LD) Am J Med 1981 Dec;71(6):1009-26 74 Citations |
| 1 | Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. (Hirsh PD, Hillis LD, Campbell WB, Firth BG, Willerson JT) N Engl J Med 1981 Mar 19;304(12):685-91 490 Citations |
